Font Size: Increase Decrease

BioDelivery Sciences (BDS) Announces $1.3M U.S. Army Grant

FREE Breaking News Alerts from StreetInsider.com!

More News related to BDSI

BioDelivery (BDSI) Files $40M Mixed Shelf
Unusual 11 Midday Movers (FBN) (BDSI) (QRM) Higher; (BGFV) (WSM) (CIS) Lower
Morning Movers 01/12: (BDSI) (MFLX) (BWEN) Higher; (EK) (BGFV) (WSM) (INFY) Lower
Unusual 11 Midday Movers 01/06: (BDSI) (REE) (SABA) (DNDN) Higher; (DRRX) (RFMD) (IART) Lower
Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower

More News related to BDSI

More News related to Corporate News

ITT Corp (ITT) Reschedules 2011 Results, FY12 Guidance Release
JetBlue (JBLU) Load Factor Rose 0.7 Points in January
MF (MFGLQ) trustee says at least $1.6B gap between claims and assets -Bloomberg
eBay's (EBAY) PayPal to offer retailers pricing and data, subsidize new service; wants to be displayed alongside Visa, MasterCard, etc. -Reuters
SkyWest (SKYW) Load Factor Rose 2 Points in January

More News related to Corporate News

October 6, 2009 8:57 AM EDT

BioDelivery Sciences International, Inc. (Nasdaq: BDSI) received a $1.3 million grant from the Walter Reed Army Institute of Research for Bioral Amphotericin B, an oral formulation of the fungicidal treatment amphotericin B in BDSI’s patented Bioral drug delivery technology, to further study the formulation in the treatment of Cutaneous Leishmaniasis.